How can we prevent viral reactivation in liver transplantation from donors with latent hepatitis B virus infection?
J Gastroenterol
.
2001 Mar;36(3):212-3.
doi: 10.1007/s005350170132.
Authors
H Marusawa
,
T Chiba
PMID:
11291887
DOI:
10.1007/s005350170132
No abstract available
Publication types
Editorial
MeSH terms
Graft Survival
Hepatitis B / complications
Hepatitis B / etiology
Hepatitis B / prevention & control*
Hepatitis C / complications
Hepatitis C / prevention & control
Humans
Liver Transplantation / adverse effects*